GM9-16088-35050
3 vaccinations
1 coded response
36 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 197 / DE
- Registered
- 2021-06-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-29
Dose 1 — Pfizer-BioNTech
-
2021-06-01
Registered in v-safe
- 2021-06-01
- 2021-06-02
- 2021-06-03
- 2021-06-04
- 2021-06-05
- 2021-06-12
-
2021-06-19
Dose 2 — Pfizer-BioNTech
- 2021-06-19
-
2021-06-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
- 2021-06-21
- 2021-06-22
- 2021-06-23
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-07-03
- 2021-07-10
- 2021-07-17
- 2021-07-24
- 2021-07-31
- 2021-09-18
- 2021-12-18
-
2021-12-21
Dose 3 — Pfizer-BioNTech
-
2021-12-22
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
- 2021-12-24
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-01-25
- 2022-02-01
- 2022-03-22
-
2022-06-21
Survey response — 6 months, dose 3MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: FairFree text: Experienced 2 colds. First with a fever, cough, congestion, body aches. Second with cough, congestion, sore throat. Tested negative for covid both times.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-29 | Pfizer-BioNTech | |
| 2 | 2021-06-19 | Pfizer-BioNTech | No |
| 3 | 2021-12-21 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3
Symptoms: Experienced 2 colds. First with a fever, cough, congestion, body aches. Second with cough, congestion, sore throat. Tested negative for covid both times.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release